Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 4 | 2020 | 1600 | 1.210 |
Why?
|
Agammaglobulinemia | 4 | 2022 | 174 | 1.190 |
Why?
|
Bayes Theorem | 3 | 2019 | 2357 | 0.890 |
Why?
|
Inappropriate Prescribing | 2 | 2017 | 212 | 0.870 |
Why?
|
Patient Selection | 2 | 2024 | 4265 | 0.780 |
Why?
|
Immune System Diseases | 1 | 2023 | 253 | 0.740 |
Why?
|
Patient Transfer | 4 | 2011 | 792 | 0.730 |
Why?
|
Health Status Disparities | 2 | 2023 | 1886 | 0.690 |
Why?
|
Medical Errors | 7 | 2016 | 1262 | 0.670 |
Why?
|
Insurance Claim Review | 1 | 2020 | 746 | 0.510 |
Why?
|
False Positive Reactions | 2 | 2016 | 963 | 0.510 |
Why?
|
Mesalamine | 1 | 2016 | 134 | 0.510 |
Why?
|
Biological Factors | 1 | 2016 | 158 | 0.500 |
Why?
|
Classification | 2 | 2017 | 128 | 0.480 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 663 | 0.480 |
Why?
|
Continuity of Patient Care | 2 | 2013 | 1076 | 0.480 |
Why?
|
Risk Management | 4 | 2015 | 558 | 0.470 |
Why?
|
Medical Informatics | 7 | 2016 | 742 | 0.460 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 468 | 0.450 |
Why?
|
Early Detection of Cancer | 4 | 2017 | 3238 | 0.440 |
Why?
|
Population Surveillance | 2 | 2014 | 2597 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.400 |
Why?
|
Urban Population | 1 | 2020 | 2045 | 0.400 |
Why?
|
Drug Interactions | 1 | 2017 | 1421 | 0.400 |
Why?
|
Biological Products | 1 | 2021 | 944 | 0.390 |
Why?
|
Clinical Laboratory Information Systems | 1 | 2012 | 108 | 0.390 |
Why?
|
Transportation of Patients | 1 | 2013 | 177 | 0.390 |
Why?
|
Antirheumatic Agents | 1 | 2021 | 1381 | 0.380 |
Why?
|
Signal Detection, Psychological | 1 | 2011 | 84 | 0.380 |
Why?
|
Suicide, Attempted | 1 | 2020 | 1409 | 0.370 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8055 | 0.360 |
Why?
|
Mammography | 3 | 2017 | 2434 | 0.350 |
Why?
|
Secondary Prevention | 1 | 2016 | 1476 | 0.340 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2024 | 3447 | 0.340 |
Why?
|
Respiratory Sounds | 1 | 2014 | 702 | 0.330 |
Why?
|
Rural Population | 1 | 2020 | 2322 | 0.330 |
Why?
|
Infection Control | 3 | 2013 | 984 | 0.320 |
Why?
|
Benzodiazepines | 1 | 2015 | 1139 | 0.320 |
Why?
|
Alcoholism | 1 | 2019 | 1981 | 0.310 |
Why?
|
Insurance, Health | 2 | 2019 | 2518 | 0.310 |
Why?
|
Reminder Systems | 1 | 2011 | 388 | 0.300 |
Why?
|
Automation | 1 | 2010 | 589 | 0.290 |
Why?
|
Databases, Factual | 5 | 2017 | 8095 | 0.290 |
Why?
|
Prostate-Specific Antigen | 1 | 2017 | 2487 | 0.280 |
Why?
|
Child | 13 | 2024 | 80969 | 0.270 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2277 | 0.270 |
Why?
|
Equipment Failure Analysis | 3 | 2015 | 848 | 0.260 |
Why?
|
Social Support | 2 | 2015 | 2193 | 0.260 |
Why?
|
Safety Management | 2 | 2015 | 765 | 0.250 |
Why?
|
Mental Health | 1 | 2020 | 3275 | 0.250 |
Why?
|
Guideline Adherence | 2 | 2013 | 2240 | 0.250 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 937 | 0.250 |
Why?
|
United States | 13 | 2024 | 73180 | 0.240 |
Why?
|
Adolescent | 12 | 2024 | 89247 | 0.230 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2189 | 0.230 |
Why?
|
Algorithms | 3 | 2020 | 14199 | 0.230 |
Why?
|
Length of Stay | 1 | 2018 | 6525 | 0.230 |
Why?
|
Retrospective Studies | 14 | 2022 | 81892 | 0.230 |
Why?
|
Pediatrics | 1 | 2019 | 3628 | 0.220 |
Why?
|
Crohn Disease | 1 | 2016 | 2297 | 0.220 |
Why?
|
Humans | 46 | 2024 | 768887 | 0.220 |
Why?
|
Radiology Department, Hospital | 3 | 2013 | 409 | 0.220 |
Why?
|
Registries | 1 | 2019 | 8384 | 0.210 |
Why?
|
Warts | 1 | 2022 | 66 | 0.200 |
Why?
|
Health Expenditures | 1 | 2015 | 2396 | 0.200 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2024 | 550 | 0.200 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2260 | 0.190 |
Why?
|
Young Adult | 8 | 2024 | 60110 | 0.190 |
Why?
|
Nijmegen Breakage Syndrome | 1 | 2021 | 4 | 0.190 |
Why?
|
Mass Screening | 4 | 2018 | 5455 | 0.180 |
Why?
|
New South Wales | 2 | 2018 | 69 | 0.180 |
Why?
|
Disease Progression | 4 | 2023 | 13677 | 0.180 |
Why?
|
Founder Effect | 1 | 2021 | 185 | 0.170 |
Why?
|
Asthma | 2 | 2021 | 6293 | 0.170 |
Why?
|
Interprofessional Relations | 2 | 2017 | 997 | 0.170 |
Why?
|
Lymphopenia | 1 | 2022 | 299 | 0.170 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21187 | 0.170 |
Why?
|
Adult | 14 | 2024 | 223818 | 0.160 |
Why?
|
Common Variable Immunodeficiency | 1 | 2019 | 100 | 0.160 |
Why?
|
Inpatients | 1 | 2010 | 2570 | 0.150 |
Why?
|
Epilepsy | 1 | 2014 | 3326 | 0.150 |
Why?
|
Communication | 1 | 2013 | 3908 | 0.150 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7460 | 0.150 |
Why?
|
Female | 18 | 2024 | 397464 | 0.150 |
Why?
|
Lymphoproliferative Disorders | 1 | 2021 | 529 | 0.140 |
Why?
|
Survival Analysis | 2 | 2020 | 10115 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 893 | 0.140 |
Why?
|
Artificial Intelligence | 1 | 2012 | 2665 | 0.140 |
Why?
|
Male | 16 | 2024 | 365249 | 0.140 |
Why?
|
Rare Diseases | 1 | 2022 | 630 | 0.130 |
Why?
|
Hospitals, Teaching | 2 | 2011 | 1157 | 0.130 |
Why?
|
Hospitals, Urban | 1 | 2018 | 499 | 0.130 |
Why?
|
American Cancer Society | 1 | 2016 | 69 | 0.130 |
Why?
|
Equipment Failure | 2 | 2015 | 585 | 0.130 |
Why?
|
North America | 1 | 2019 | 1290 | 0.120 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7472 | 0.120 |
Why?
|
Prevalence | 5 | 2021 | 15875 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 419 | 0.120 |
Why?
|
Child, Preschool | 5 | 2021 | 42684 | 0.120 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11229 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 558 | 0.110 |
Why?
|
Computer Communication Networks | 1 | 2015 | 295 | 0.110 |
Why?
|
Middle Aged | 11 | 2024 | 223740 | 0.110 |
Why?
|
Comorbidity | 2 | 2019 | 10591 | 0.110 |
Why?
|
Insurance Claim Reporting | 1 | 2014 | 166 | 0.110 |
Why?
|
Research | 1 | 2022 | 1981 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26384 | 0.110 |
Why?
|
Organizational Case Studies | 2 | 2011 | 301 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2021 | 2167 | 0.100 |
Why?
|
Genome, Viral | 1 | 2016 | 673 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2019 | 2730 | 0.100 |
Why?
|
Postoperative Period | 1 | 2016 | 1830 | 0.090 |
Why?
|
Consensus | 1 | 2021 | 3214 | 0.090 |
Why?
|
Colectomy | 1 | 2016 | 699 | 0.090 |
Why?
|
Public Opinion | 1 | 2015 | 486 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2026 | 0.090 |
Why?
|
User-Computer Interface | 2 | 2015 | 1406 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2012 | 5323 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2008 | 0.090 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4568 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 915 | 0.090 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2009 | 18 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1752 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1462 | 0.080 |
Why?
|
Observation | 1 | 2011 | 311 | 0.080 |
Why?
|
Odds Ratio | 1 | 2022 | 9682 | 0.080 |
Why?
|
Data Mining | 1 | 2015 | 563 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1515 | 0.080 |
Why?
|
Regression Analysis | 1 | 2019 | 6346 | 0.080 |
Why?
|
Cohort Studies | 4 | 2018 | 41800 | 0.080 |
Why?
|
Age Factors | 2 | 2017 | 18454 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3450 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 826 | 0.080 |
Why?
|
Computer Systems | 1 | 2010 | 470 | 0.080 |
Why?
|
Hepacivirus | 1 | 2016 | 1344 | 0.080 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1907 | 0.080 |
Why?
|
Folic Acid Deficiency | 1 | 2009 | 117 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 497 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2019 | 20244 | 0.080 |
Why?
|
Colon | 1 | 2016 | 1804 | 0.080 |
Why?
|
Aged | 7 | 2024 | 171790 | 0.080 |
Why?
|
Computer Simulation | 2 | 2012 | 6289 | 0.080 |
Why?
|
Research Report | 1 | 2011 | 369 | 0.080 |
Why?
|
Cause of Death | 1 | 2018 | 3721 | 0.070 |
Why?
|
Femur Head | 1 | 2009 | 297 | 0.070 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2011 | 465 | 0.070 |
Why?
|
Safety | 1 | 2011 | 1159 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3438 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2108 | 0.070 |
Why?
|
Medical Order Entry Systems | 1 | 2011 | 523 | 0.070 |
Why?
|
United States Food and Drug Administration | 2 | 2011 | 1672 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5803 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1673 | 0.060 |
Why?
|
Hepatitis C | 1 | 2016 | 1595 | 0.060 |
Why?
|
Natural Language Processing | 2 | 2015 | 1203 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13510 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2010 | 831 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3490 | 0.060 |
Why?
|
Infant | 2 | 2019 | 36541 | 0.060 |
Why?
|
Causality | 1 | 2010 | 1255 | 0.060 |
Why?
|
Patient Care Team | 1 | 2015 | 2527 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8512 | 0.060 |
Why?
|
Risk Factors | 4 | 2021 | 74971 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2021 | 65485 | 0.050 |
Why?
|
Information Dissemination | 1 | 2011 | 1141 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9549 | 0.050 |
Why?
|
Vaccination | 1 | 2015 | 3436 | 0.050 |
Why?
|
Medicare | 1 | 2020 | 6888 | 0.050 |
Why?
|
Research Design | 1 | 2017 | 6213 | 0.050 |
Why?
|
Europe, Eastern | 1 | 2021 | 72 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2021 | 39394 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2012 | 3580 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 2021 | 309 | 0.040 |
Why?
|
Health Personnel | 1 | 2013 | 3382 | 0.040 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2009 | 1421 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26394 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2589 | 0.040 |
Why?
|
Workflow | 2 | 2015 | 859 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 729 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 992 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2021 | 549 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5375 | 0.030 |
Why?
|
Risk Assessment | 2 | 2016 | 24330 | 0.030 |
Why?
|
Bone Density | 1 | 2009 | 3573 | 0.030 |
Why?
|
Prospective Studies | 2 | 2011 | 54950 | 0.030 |
Why?
|
Software Design | 1 | 2016 | 173 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
Viral Nonstructural Proteins | 1 | 2016 | 228 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 192 | 0.030 |
Why?
|
Computer Security | 1 | 2016 | 260 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 839 | 0.030 |
Why?
|
England | 1 | 2015 | 533 | 0.030 |
Why?
|
State Medicine | 1 | 2015 | 219 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1893 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 965 | 0.030 |
Why?
|
Health Status | 1 | 2024 | 4095 | 0.020 |
Why?
|
Consumer Product Safety | 1 | 2011 | 122 | 0.020 |
Why?
|
Patient Identification Systems | 1 | 2011 | 75 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2525 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2635 | 0.020 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2009 | 119 | 0.020 |
Why?
|
Virus Replication | 1 | 2016 | 2458 | 0.020 |
Why?
|
RNA, Viral | 1 | 2016 | 2871 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.020 |
Why?
|
Government Regulation | 1 | 2011 | 525 | 0.020 |
Why?
|
Australia | 1 | 2010 | 1265 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 2009 | 528 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4794 | 0.020 |
Why?
|
Attitude to Health | 1 | 2015 | 2025 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1177 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2542 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12563 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3069 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1757 | 0.010 |
Why?
|
Body Height | 1 | 2009 | 1568 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10097 | 0.010 |
Why?
|
Folic Acid | 1 | 2009 | 1336 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21545 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12798 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16051 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15603 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10276 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15955 | 0.010 |
Why?
|
Osteoporosis | 1 | 2009 | 1606 | 0.010 |
Why?
|
Body Weight | 1 | 2009 | 4628 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22294 | 0.010 |
Why?
|
Software | 1 | 2011 | 4480 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4879 | 0.010 |
Why?
|
Mice | 1 | 2018 | 82074 | 0.010 |
Why?
|
Animals | 1 | 2018 | 169408 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_